Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
In type I diabetes mellitus (T1DM) pancreatic β cells are destroyed. Treatment entails exogenous insulin administration and strict diet control, yet optimal glycemic control is hardly attainable. Islet transpl...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Claudia Jara, Felipe Oyarzun-Ampuero, Flavio Carri ón, Esteban González-Echeverría, Claudio Cappelli and Pablo Caviedes Tags: Research Source Type: research
More News: Diabetes | Diabetes Mellitus | Diets | Endocrinology | Insulin | Metabolic Syndrome | Nutrition | Pancreas | Stem Cell Therapy | Stem Cells